{"nct_id":"NCT05325866","title":"A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2022-09-23","start_date_type":"ACTUAL","primary_completion_date":"2026-02-06","primary_completion_date_type":"ESTIMATED","completion_date":"2026-02-06","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["AMGN"]}